Phase I Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Palbociclib (Primary) ; Decitabine; Dexamethasone; Sorafenib
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 21 Feb 2018 Planned End Date changed from 1 Jul 2020 to 1 Jul 2021.
- 02 Aug 2017 Planned End Date changed from 1 Sep 2020 to 1 Jul 2020.